What is the cost of Kymriah?
Kymriah (tisagenlecleucel) is an expensive CAR-T cell cancer therapy costs over $612,000 for one treatment infusion, but most people do not pay this amount. In addition, the Centers for Medicare & Medicaid Services (CMS) states that CAR-T cell therapy would be covered for eligible people with Medicare.
- Kymriah is a chimeric antigen receptor T cell (CAR-T) therapy for use in pediatric and young adult patients (up to age 25) with relapsed or refractory (r/r) B-cell acute lymphoblastic leukemia (ALL).
- It is also approved to treat relapsed or refractory large b-cell lymphoma in adults after two or more therapies. It is not used for treatment of patients with primary central nervous system lymphoma.
- It is used to treat adult patients with relapsed or refractory follicular lymphoma (FL) after two or more therapies.
Kymriah is usually given by a health care provider in a clinic or hospital and is not found in a traditional pharmacy. The cost for this medicine may be covered by your insurance but you may have a deductible, copay and / or coinsurance. It is given as one single treatment infusion but involves hospitalization and close monitoring by healthcare providers for several weeks or months.
Kymriah Cares, a support program from Novartis, offers assistance to eligible patients to help them gain access to treatment. Your questions related to the medicine and administration, treatment center locations, or insurance coverage can be directed to Kymriah Cares at 1-844-459-6742 8AM to 8PM ET.
View the drugclasses.com Kymriah Price Guide to learn more about costs, copay programs and patient financial assistance.
Related questions
- What is the survival rate of Kymriah?
- What's the difference between Kymriah and Yescarta?
- How is Kymriah administered?
Does Medicare pay for Kymriah?
In August 2019, the Centers for Medicare & Medicaid Services (CMS) announced that CAR-T cell therapy would be covered for all patients with Medicare. You still may have deductibles, copays, coinsurance or other costs. Ask your physician for more information.
Most people do not pay out-of-pocket for the full price of Kymriah. Your cost will vary based on your insurance coverage or other financial assistance. Novartis may be able to provide this drug for free if you have been denied coverage or do not have insurance.
If you have more questions about Kymriah treatment, treatment center locations, Medicare / Medicaid, or other insurance coverage, you can contact Novartis at 1-844-4KYMRIAH (1-844-459-6742), 8AM to 8PM ET for more information.
This is not all the information you need to know about Kymriah and does not take the place of your doctor’s directions. Prices and savings programs are subject to change. Discuss any medical questions you have with your doctor or other health care provider.
References
- Support Resources for Kymriah. Kymriah.com. Accessed April 11, 2024 at https://www.us.kymriah.com/acute-lymphoblastic-leukemia-children/patient-support/support-resources-for-kymriah/
- Novartis Can Provide CAR-T Therapy for Free, OIG Says. WCG FDANews. March 30, 2021. Accessed April 11, 2024 at https://www.fdanews.com/articles/202098-novartis-can-provide-car-t-therapy-for-free-oig-says
- Medicare to Cover CAR-T Cell Therapy. Cancer Today. Dec. 23, 2019. Accessed April 11, 2024 at https://www.cancertodaymag.org/Pages/Winter2019-2020/Medicare-to-Cover-CAR-T-Cell-Therapy.aspx
- Centers for Medicare and Medicaid Services (CMS). CMS.gov. Accessed April 11, 2024 at https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&NCAId=291
Read next
What type of drug is Kymriah (tisagenlecleucel)?
Kymriah (tisagenlecleucel) is a chimeric antigen receptor T cell (CAR-T) therapy. In CAR-T cell therapy, a patient's cells are genetically modified to include a new protein that directs that specific white blood cell (known as T-cell) to target and kill leukemia cells. Continue reading
What is the success rate of Breyanzi?
Everyone will respond differently to Breyanzi (lisocabtagene maraleucel), and the success rate for someone else may be different than for you. Based on clinical trial data, the complete response rate in patients taking Breyanzi is around 20% to 73%, depending on the condition being treated. Continue reading
What is the success rate of Rituxan (rituximab) in patients with blood cancers?
In patients with hematological or blood cancers, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL), Rituxan’s success is measured in a number of ways. It is measured by looking at how long patients responded to treatment (median duration of response), how long they live without their disease progressing (progression-free survival) and how many patients respond to treatment (response rate).
Rituxan treatment improves outcomes in certain patients with NHL. Adding Rituxan alongside standard therapies enhances the response patients have to treatment and improves overall outcomes, including increasing the time patients live for without experiencing a progression of their disease.
Rituxan helps to improve overall survival in certain patients with CLL and also helps to increase the time patients live for without experiencing disease progression. Adding Rituxan alongside standard therapy enhances the response patients have to therapy. Continue reading
Related medical questions
- What is the difference between Truxima and Rituxan?
- Does Truxima make you gain weight?
- What are the names of the BTK inhibitors?
- What is Zydelig used for and how does it work?
- What is the success rate of Epkinly?
- What is the difference between Rituxan and Rituxan Hycela?
- How is Rituxan Hycela administered?
- What type of drug is Copiktra?
- What type of drug is Yescarta (axicabtagene ciloleucel)?
- What is glofitamab?
- How does Besponsa work to treat Acute Lymphoblastic Leukemia (ALL)?
- What is the lifetime or cumulative dose for Adriamycin?
- What to avoid when taking Gleevec?
- How much does Tecartus cost?
- Gleevec vs Sprycel vs Tasigna - how do they compare?
- How much does Blincyto (blinatumomab) cost?
- How long does it take Sprycel (dasatinib) to start working?
- Is there a generic for Gleevec?
- Is Sprycel a chemotherapy drug?
- How does Gleevec (imatinib) work?
- Is Tecartus a one-time treatment?
- Is Tasigna a form of chemotherapy?
- Is Blincyto (blinatumomab) chemotherapy?
- Can I take Gleevec while pregnant?
- How is Blincyto taken / administered?
- How does Asparlas (calaspargase pegol-mknl) compare to Oncaspar (pegaspargase)?
Drug information
- Kymriah Information for Consumers
- Kymriah prescribing info & package insert (for Health Professionals)
- Side Effects of Kymriah (detailed)
Related support groups
- Kymriah (5 questions, 3 members)
- Follicular Lymphoma (15 questions, 15 members)
- B Cell Lymphoma (5 questions, 3 members)
- Acute Lymphoblastic Leukemia (22 questions, 15 members)